## Core Concept
The syndromic management of urethral discharge involves treating the symptoms and likely causes of urethritis without waiting for laboratory confirmation. This approach is crucial in sexually transmitted infections (STIs) where prompt treatment can prevent long-term complications and transmission to partners. Urethral discharge is often caused by **Neisseria gonorrhoeae** and **Chlamydia trachomatis**.

## Why the Correct Answer is Right
The correct approach to syndromic management of urethral discharge includes providing empirical antibiotic treatment that covers both gonorrhea and chlamydia. The recommended regimen often includes a **ceftriaxone** injection for gonorrhea and **azithromycin** or **doxycycline** for chlamydia. This dual therapy is essential due to the high prevalence of co-infection and the increasing resistance of **N. gonorrhoeae** to antibiotics.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not provide a comprehensive treatment approach for both gonorrhea and chlamydia, which are the most common causes of urethral discharge.
- **Option B:** This option might be incomplete as it does not specify the full treatment regimen that is typically recommended for syndromic management.
- **Option D:** This option is incorrect because it likely does not include the recommended dual therapy for gonorrhea and chlamydia.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the syndromic management of urethral discharge aims to treat the most likely causes of STIs promptly. The **WHO** and other health organizations recommend **ceftriaxone** plus **azithromycin** as a first-line treatment. It's also crucial to counsel patients on the importance of returning for test results and completing the full treatment course.

## Correct Answer Line
**Correct Answer: C.**